Brief: Firebrick Pharma Ltd Seeks Trading Halt-Fre.Ax
07/07/2022 24:39
July 7 (Reuters) - Firebrick Pharma Ltd FRE.AX :
* TRADING HALT-FRE.AX
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON OUTCOME OF
APPEAL
FILED AGAINST TGA'S DECISION TO NOT APPROVE NASODINE SALE IN
AUSTRALIA
Source text for Eikon: ID:nASXbF70y3
Further company coverage: FRE.AX
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement